These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23894097)

  • 21. Design and Synthesis of Water-Soluble and Potent MMP-13 Inhibitors with Activity in Human Osteosarcoma Cells.
    Zapico JM; Acosta L; Pastor M; Rangasamy L; Marquez-Cantudo L; Coderch C; Ortin I; Nicolau-Sanus M; Puchades-Carrasco L; Pineda-Lucena A; Majali-Martinez A; Ramos P; de Pascual-Teresa B; Ramos A
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure of matrix metalloproteinase-3 with a platinum-based inhibitor.
    Belviso BD; Caliandro R; Siliqi D; Calderone V; Arnesano F; Natile G
    Chem Commun (Camb); 2013 Jun; 49(48):5492-4. PubMed ID: 23660647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fragment-Based Discovery of 5-Arylisatin-Based Inhibitors of Matrix Metalloproteinases 2 and 13.
    Agamennone M; Belov DS; Laghezza A; Ivanov VN; Novoselov AM; Andreev IA; Ratmanova NK; Altieri A; Tortorella P; Kurkin AV
    ChemMedChem; 2016 Sep; 11(17):1892-8. PubMed ID: 27418256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Probing the S1' site for the identification of non-zinc-binding MMP-2 inhibitors.
    Di Pizio A; Laghezza A; Tortorella P; Agamennone M
    ChemMedChem; 2013 Sep; 8(9):1475-82, 1421. PubMed ID: 23873724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis, and biological activity of novel, potent, and highly selective fused pyrimidine-2-carboxamide-4-one-based matrix metalloproteinase (MMP)-13 zinc-binding inhibitors.
    Nara H; Sato K; Kaieda A; Oki H; Kuno H; Santou T; Kanzaki N; Terauchi J; Uchikawa O; Kori M
    Bioorg Med Chem; 2016 Dec; 24(23):6149-6165. PubMed ID: 27825552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a putative Zn
    Fuerst R; Choi JY; Knapinska AM; Cameron MD; Ruiz C; Delmas A; Sundrud MS; Fields GB; Roush WR
    Bioorg Med Chem Lett; 2022 Nov; 76():129014. PubMed ID: 36202189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of matrix metalloproteinase inhibitors by chemical arrays.
    Kawatani M; Fukushima Y; Kondoh Y; Honda K; Sekine T; Yamaguchi Y; Taniguchi N; Osada H
    Biosci Biotechnol Biochem; 2015; 79(10):1597-602. PubMed ID: 25988721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of derivatives of methyl rosmarinate and their inhibitory activities against matrix metalloproteinase-1 (MMP-1).
    Yuan H; Lu W; Wang L; Shan L; Li H; Huang J; Sun Q; Zhang W
    Eur J Med Chem; 2013 Apr; 62():148-57. PubMed ID: 23353736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple receptor-ligand based pharmacophore modeling and molecular docking to screen the selective inhibitors of matrix metalloproteinase-9 from natural products.
    Gao Q; Wang Y; Hou J; Yao Q; Zhang J
    J Comput Aided Mol Des; 2017 Jul; 31(7):625-641. PubMed ID: 28623487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetic characterization of 4,4'-biphenylsulfonamides as selective non-zinc binding MMP inhibitors.
    Santamaria S; Nuti E; Cercignani G; La Regina G; Silvestri R; Supuran CT; Rossello A
    J Enzyme Inhib Med Chem; 2015 Dec; 30(6):947-54. PubMed ID: 25694065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An integrated computational approach to rationalize the activity of non-zinc-binding MMP-2 inhibitors.
    Di Pizio A; Agamennone M; Aschi M
    PLoS One; 2012; 7(11):e47774. PubMed ID: 23144829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-Zinc-Binding Inhibitors of MMP-13: GRID-Based Approaches to Rationalize the Binding Process.
    Di Pizio A; Agamennone M; Tortorella P
    Curr Top Med Chem; 2016; 16(4):449-59. PubMed ID: 26268339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Directed evolution of the metalloproteinase inhibitor TIMP-1 reveals that its N- and C-terminal domains cooperate in matrix metalloproteinase recognition.
    Raeeszadeh-Sarmazdeh M; Greene KA; Sankaran B; Downey GP; Radisky DC; Radisky ES
    J Biol Chem; 2019 Jun; 294(24):9476-9488. PubMed ID: 31040180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trivalent metal ions based on inorganic compounds with in vitro inhibitory activity of matrix metalloproteinase 13.
    Wen H; Qin Y; Zhong W; Li C; Liu X; Shen Y
    Enzyme Microb Technol; 2016 Oct; 92():9-17. PubMed ID: 27542739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virtual Screening on MMP-13 Led to Discovering New Inhibitors Including a Non-Zinc Binding and a Micro Molar One: A Successful Example of Receptor Selection According to Cross-Docking Results for a Flexible Enzyme.
    Ramezani M; Shamsara J
    Comb Chem High Throughput Screen; 2017; 20(8):719-725. PubMed ID: 28814230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A study on quantitative structure-activity relationship and molecular docking of metalloproteinase inhibitors based on L-tyrosine scaffold.
    Abbasi M; Ramezani F; Elyasi M; Sadeghi-Aliabadi H; Amanlou M
    Daru; 2015 Apr; 23(1):29. PubMed ID: 25925871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biphenyl substituted lysine derivatives as recognition elements for the matrix metalloproteinases MMP-2 and MMP-9.
    Kirchhain A; Zubrienė A; Kairys V; Vivaldi F; Bonini A; Biagini D; Santalucia D; Matulis D; Di Francesco F
    Bioorg Chem; 2021 Oct; 115():105155. PubMed ID: 34303036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design and synthesis of MMP inhibitors with appended fluorescent tags for imaging and visualization of matrix metalloproteinase enzymes.
    Freskos JN; Asmelash B; Gaston KR; Karwa A; Marzan TA; Nickols MA; Rogers TE; Schoenstein T; Sympson CJ; Vu B
    Bioorg Med Chem Lett; 2013 Oct; 23(20):5566-70. PubMed ID: 23999043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New selective inhibitors of MMP-13 for inflammatory diseases: a patent evaluation (W02012151158).
    Li NG; Tang YP; Duan JA
    Expert Opin Ther Pat; 2013 May; 23(5):669-75. PubMed ID: 23506002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of Novel Natural Product Inhibitors against Matrix Metalloproteinase 9 Using Quantum Mechanical Fragment Molecular Orbital-Based Virtual Screening Methods.
    Lim H; Hong H; Hwang S; Kim SJ; Seo SY; No KT
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.